Clinical Value of Absolute Quantification of Myocardial Perfusion With 15O-Water in Coronary Artery Disease

Background— The standard interpretation of perfusion imaging is based on the assessment of relative perfusion distribution. The limitations of that approach have been recognized in patients with multivessel disease and endothelial dysfunction. To date, however, no large clinical studies have investigated the value of measuring quantitative blood flow and compared that with relative uptake. Methods and Results— One hundred four patients with moderate (30%–70%) pretest likelihood of coronary artery disease (CAD) underwent PET imaging during adenosine stress using 15O-water and dynamic imaging. Absolute myocardial blood flow was calculated from which both standard relative myocardial perfusion images and images scaled to a known absolute scale were produced. The patients and the regions then were classified as normal or abnormal and compared against the reference of conventional angiography with fractional flow reserve. In patient-based analysis, the positive predictive value, negative predictive value, and accuracy of absolute perfusion in the detection of any obstructive CAD were 86%, 97%, and 92%, respectively, with absolute quantification. The corresponding values with relative analysis were 61%, 83%, and 73%, respectively. In region-based analysis, the receiver operating characteristic curves confirmed that the absolute quantification was superior to relative assessment. In particular, the specificity and positive predictive value were low using just relative differences in flow. Only 9 of 24 patients with 3-vessel disease were correctly assessed using relative analysis. Conclusions— The measurement of myocardial blood flow in absolute terms has a significant impact on the interpretation of myocardial perfusion. As expected, multivessel disease is more accurately detected. Clinical Trial Registration— URL: http://www.clinicaltrials.gov. Unique identifier: NCT00627172.

[1]  M Teräs,et al.  Low radiation dose imaging of myocardial perfusion and coronary angiography with a hybrid PET/CT scanner , 2009, Clinical physiology and functional imaging.

[2]  A. Luxen,et al.  Direct Comparison of [13N]Ammonia and [150]Water Estimates of Perfusion With Quantification of Regional Myocardial Blood Flow by Microspheres , 1993, Circulation.

[3]  Paul E. Christian,et al.  Nuclear Medicine and PET: Technology and Techniques , 2003 .

[4]  Nicola Fox,et al.  Cardiovascular system. , 2007, Nursing Standard.

[5]  J. van den Hoff,et al.  Quantitative myocardial perfusion PET combined with coronary anatomy derived from CT angiography: validation of a new fusion and visualisation software. , 2009, Zeitschrift fur medizinische Physik.

[6]  H. Sipilä,et al.  Cardiac Positron Emission Tomography/Computed Tomography Imaging Accurately Detects Anatomically and Functionally Significant Coronary Artery Disease , 2010, Circulation.

[7]  J. Viikari,et al.  Coronary flow reserve in young men with familial combined hyperlipidemia. , 1999, Circulation.

[8]  U. Siebert,et al.  Fractional flow reserve versus angiography for guiding percutaneous coronary intervention. , 2009, The New England journal of medicine.

[9]  William Wijns,et al.  Long-term clinical outcome after fractional flow reserve-guided percutaneous coronary intervention in patients with multivessel disease. , 2005, Journal of the American College of Cardiology.

[10]  Akira Kitabatake,et al.  Reduction of coronary flow reserve in areas with and without ischemia on stress perfusion imaging in patients with coronary artery disease: A study using oxygen 15-labeled water PET , 2003, Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology.

[11]  P. Kaufmann,et al.  Myocardial blood flow measurement by PET: technical aspects and clinical applications. , 2005, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[12]  T. Masuoka,et al.  Quantitative measurement of regional myocardial blood flow in patients with coronary artery disease by intravenous injection of13N-ammonia in positron emission tomography , 2004, European Journal of Nuclear Medicine.

[13]  Juhani Knuuti,et al.  Quantification of myocardial blood flow will reform the detection of CAD , 2009, Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology.

[14]  S. Nekolla,et al.  Evaluation of the Novel Myocardial Perfusion Positron-Emission Tomography Tracer 18F-BMS-747158-02: Comparison to 13N-Ammonia and Validation With Microspheres in a Pig Model , 2009, Circulation.

[15]  Terrence D. Ruddy,et al.  Potential utility of rubidium 82 pet quantification in patients with 3-vessel coronary artery disease , 2004, Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology.

[16]  Kenneth A Ellenbogen,et al.  2011 ACCF/AHA/HRS focused update on the management of patients with atrial fibrillation (Updating the 2006 Guideline): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. , 2011, Journal of the American College of Cardiology.

[17]  O Muzik,et al.  Early Detection of Abnormal Coronary Flow Reserve in Asymptomatic Men at High Risk for Coronary Artery Disease Using Positron Emission Tomography , 1994, Circulation.

[18]  Georges El Fakhri,et al.  QDA: An automated graphical software for absolute quantitation of regional myocardial blood flow , 2007 .

[19]  Georges El Fakhri,et al.  Reproducibility and Accuracy of Quantitative Myocardial Blood Flow Assessment with 82Rb PET: Comparison with 13N-Ammonia PET , 2009, Journal of Nuclear Medicine.

[20]  E. Antman,et al.  ACC/AHA/ASNC guidelines for the clinical use of cardiac radionuclide imaging--executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/ASNC Committee to Revise the 1995 Guidelines for the Clinical Use of Cardiac Radionucl , 2003, Journal of the American College of Cardiology.

[21]  N. Pijls Optimum guidance of complex PCI by coronary pressure measurement , 2004, Heart.

[22]  J. Knuuti,et al.  Myocardial perfusion quantitation with 15O-labelled water PET: high reproducibility of the new cardiac analysis software (Carimas™) , 2009, European Journal of Nuclear Medicine and Molecular Imaging.

[23]  A. Fischman,et al.  Comparison of positron emission tomography measurement of adenosine-stimulated absolute myocardial blood flow versus relative myocardial tracer content for physiological assessment of coronary artery stenosis severity and location. , 2009, JACC. Cardiovascular imaging.

[24]  N. Simionescu,et al.  The Cardiovascular System , 1983 .

[25]  M. Schwaiger,et al.  Assessment of diagnostic performance of quantitative flow measurements in normal subjects and patients with angiographically documented coronary artery disease by means of nitrogen-13 ammonia and positron emission tomography. , 1998, Journal of the American College of Cardiology.

[26]  E. Antman,et al.  ACC/AHA/ASNC guidelines for the clinical use of cardiac radionuclide imaging--executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/ASNC Committee to Revise the 1995 Guidelines for the Clinical Use of Cardiac Radionucl , 2003, Journal of the American College of Cardiology.